308 related articles for article (PubMed ID: 34184502)
1. Problems of
Kiersnowska Z; Lemiech-Mirowska E; Ginter-Kramarczyk D; Kruszelnicka I; Michałkiewicz M; Marczak M
Ann Agric Environ Med; 2021 Jun; 28(2):224-230. PubMed ID: 34184502
[TBL] [Abstract][Full Text] [Related]
2. Application of a Novel PM Model to Assess the Risk of
Kiersnowska ZM; Lemiech-Mirowska E; Sierocka A; Zawadzki M; Michałkiewicz M; Marczak M
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010698
[TBL] [Abstract][Full Text] [Related]
3. Post-Discharge
Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
[No Abstract] [Full Text] [Related]
4. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
[TBL] [Abstract][Full Text] [Related]
5. Hand hygiene as the basic method of reducing
Kiersnowska ZM; Lemiech-Mirowska E; Michałkiewicz M; Marczak M
Ann Agric Environ Med; 2021 Dec; 28(4):535-540. PubMed ID: 34969208
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
7. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
[TBL] [Abstract][Full Text] [Related]
8. Healthcare associated
Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
[No Abstract] [Full Text] [Related]
9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
10. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Infection due to Clostridium (Clostridioides) difficile.
Krishna A; Chopra T
Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
[TBL] [Abstract][Full Text] [Related]
12. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
Spigaglia P
Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland.
Obuch-Woszczatyński P; Dubiel G; Harmanus C; Kuijper E; Duda U; Wultańska D; van Belkum A; Pituch H
Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1027-30. PubMed ID: 23443474
[TBL] [Abstract][Full Text] [Related]
14. Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
Jump RL; Riggs MM; Sethi AK; Pultz MJ; Ellis-Reid T; Riebel W; Gerding DN; Salata RA; Donskey CJ
Emerg Infect Dis; 2010 May; 16(5):827-9. PubMed ID: 20409374
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characteristics of community-acquired Clostridium difficile infections in comparison with those of hospital-acquired C. difficile.
Kwon SS; Gim JL; Kim MS; Kim H; Choi JY; Yong D; Lee K
Anaerobe; 2017 Dec; 48():42-46. PubMed ID: 28655581
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
[TBL] [Abstract][Full Text] [Related]
17. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
[TBL] [Abstract][Full Text] [Related]
18. Strategies to prevent adverse outcomes following
Rauseo AM; Olsen MA; Reske KA; Dubberke ER
Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
[No Abstract] [Full Text] [Related]
19. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent
Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA
Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153
[TBL] [Abstract][Full Text] [Related]
20. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
